Angie Gelli - Publications

Affiliations: 
Pharmacology and Toxicology University of California, Davis, Davis, CA 
Area:
Cell Biology, Pharmacy, Biochemistry

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Lanser DM, Bennett AB, Vu K, Gelli A. Macropinocytosis as a potential mechanism driving neurotropism of . Frontiers in Cellular and Infection Microbiology. 13: 1331429. PMID 38149006 DOI: 10.3389/fcimb.2023.1331429  0.517
2023 Vu K, Buckley BJ, Bujaroski RS, Blumwald E, Kelso MJ, Gelli A. Antifungal activity of 6-substituted amiloride and hexamethylene amiloride (HMA) analogs. Frontiers in Cellular and Infection Microbiology. 13: 1101568. PMID 36923593 DOI: 10.3389/fcimb.2023.1101568  0.528
2022 Bansal S, Vu K, Liu R, Ajena Y, Xiao W, Menon SM, Bennett A, Gelli A, Lam KS. Discovery and Characterization of a Potent Antifungal Peptide through One-Bead, One-Compound Combinatorial Library Screening. Acs Infectious Diseases. PMID 35700987 DOI: 10.1021/acsinfecdis.2c00019  0.465
2022 Garcia JA, Vu K, Thompson GR, Gelli A. Characterization of the Growth and Morphology of a BSL-2 Strain That Persists in the Parasitic Life Cycle at Ambient CO. Journal of Fungi (Basel, Switzerland). 8. PMID 35628711 DOI: 10.3390/jof8050455  0.483
2021 Vu K, Blumwald E, Gelli A. The Antifungal Activity of HMA, an Amiloride Analog and Inhibitor of Na/H Exchangers. Frontiers in Microbiology. 12: 673035. PMID 34025629 DOI: 10.3389/fmicb.2021.673035  0.522
2020 Aaron PA, Vu K, Gelli A. An Antivirulence Approach for Preventing Cryptococcus neoformans from Crossing the Blood-Brain Barrier via Novel Natural Product Inhibitors of a Fungal Metalloprotease. Mbio. 11. PMID 32694141 DOI: 10.1128/Mbio.01249-20  0.576
2019 Aaron PA, Gelli A. Harnessing the Activity of the Fungal Metalloprotease, Mpr1, To Promote Crossing of Nanocarriers through the Blood-Brain Barrier. Acs Infectious Diseases. PMID 31820926 DOI: 10.1021/Acsinfecdis.9B00348  0.367
2019 Vu K, Garcia JA, Gelli A. Cryptococcal Meningitis and Anti-virulence Therapeutic Strategies. Frontiers in Microbiology. 10: 353. PMID 30863389 DOI: 10.3389/Fmicb.2019.00353  0.538
2018 Na Pombejra S, Jamklang M, Uhrig JP, Vu K, Gelli A. The structure-function analysis of the Mpr1 metalloprotease determinants of activity during migration of fungal cells across the blood-brain barrier. Plos One. 13: e0203020. PMID 30161190 DOI: 10.1371/Journal.Pone.0203020  0.545
2018 Vu K, Thompson GR, Roe CC, Sykes JE, Dreibe EM, Lockhart SR, Meyer W, Engelthaler DM, Gelli A. Flucytosine resistance in Cryptococcus gattii is indirectly mediated by the FCY2-FCY1-FUR1 pathway. Medical Mycology. PMID 29554336 DOI: 10.1093/Mmy/Myx135  0.501
2017 Na Pombejra S, Salemi M, Phinney BS, Gelli A. The Metalloprotease, Mpr1, Engages AnnexinA2 to Promote the Transcytosis of Fungal Cells across the Blood-Brain Barrier. Frontiers in Cellular and Infection Microbiology. 7: 296. PMID 28713781 DOI: 10.3389/fcimb.2017.00296  0.306
2017 Vu K, Thompson GR, Roe C, Sykes J, Dreibe E, Lockhart S, Meyer W, Engelthaler DM, Gelli A. Mechanisms of Flucytosine Resistance in Cryptococcus gattii May Be Independent of the FCY2-FCY1-FUR1 Pathway Open Forum Infectious Diseases. 4: S115-S116. DOI: 10.1093/Ofid/Ofx163.134  0.503
2015 Yang ML, Uhrig J, Vu K, Singapuri A, Dennis M, Gelli A, Thompson GR. Fluconazole Susceptibility in Cryptococcus gattii is dependent on the ATP binding cassette (ABC) Transporter PDR11. Antimicrobial Agents and Chemotherapy. PMID 26643330 DOI: 10.1128/Aac.01777-15  0.504
2015 Vu K, Bautos JM, Gelli A. The Cch1-Mid1 High-Affinity Calcium Channel Contributes to the Virulence of Cryptococcus neoformans by Mitigating Oxidative Stress. Eukaryotic Cell. 14: 1135-43. PMID 26385891 DOI: 10.1128/Ec.00100-15  0.484
2014 Vu K, Tham R, Uhrig JP, Thompson GR, Na Pombejra S, Jamklang M, Bautos JM, Gelli A. Invasion of the central nervous system by Cryptococcus neoformans requires a secreted fungal metalloprotease. Mbio. 5: e01101-14. PMID 24895304 DOI: 10.1128/Mbio.01101-14  0.564
2013 Vu K, Eigenheer RA, Phinney BS, Gelli A. Cryptococcus neoformans promotes its transmigration into the central nervous system by inducing molecular and cellular changes in brain endothelial cells. Infection and Immunity. 81: 3139-47. PMID 23774597 DOI: 10.1128/Iai.00554-13  0.541
2013 Hong MP, Vu K, Bautos JM, Tham R, Jamklang M, Uhrig JP, Gelli A. Activity of the calcium channel pore Cch1 is dependent on a modulatory region of the subunit Mid1 in Cryptococcus neoformans. Eukaryotic Cell. 12: 142-50. PMID 23175710 DOI: 10.1128/Ec.00130-12  0.516
2010 Hong MP, Vu K, Bautos J, Gelli A. Cch1 restores intracellular Ca2+ in fungal cells during endoplasmic reticulum stress. The Journal of Biological Chemistry. 285: 10951-8. PMID 20123986 DOI: 10.1074/Jbc.M109.056218  0.505
2010 Vu K, Gelli A. Astemizole and an analogue promote fungicidal activity of fluconazole against Cryptococcus neoformans var. grubii and Cryptococcus gattii. Medical Mycology. 48: 255-62. PMID 19572230 DOI: 10.3109/13693780903081968  0.519
2010 Hong M, Vu K, Bautos J, Gelli A. Cch1 Restores Intracellular Calcium in Fungal Cells during ER Stress Biophysical Journal. 98: 677a. DOI: 10.1016/J.Bpj.2009.12.3718  0.546
2009 Vu K, Weksler B, Romero I, Couraud PO, Gelli A. Immortalized human brain endothelial cell line HCMEC/D3 as a model of the blood-brain barrier facilitates in vitro studies of central nervous system infection by Cryptococcus neoformans. Eukaryotic Cell. 8: 1803-7. PMID 19767445 DOI: 10.1128/Ec.00240-09  0.511
2009 Vu K, Bautos J, Hong MP, Gelli A. The functional expression of toxic genes: lessons learned from molecular cloning of CCH1, a high-affinity Ca2+ channel. Analytical Biochemistry. 393: 234-41. PMID 19580778 DOI: 10.1016/J.Ab.2009.06.039  0.5
Show low-probability matches.